Literature DB >> 13019931

The effects of hexamethonium on certain manifestations of congestive heart failure.

R T KELLEY, E D FREIS, T F HIGGINS.   

Abstract

Entities:  

Keywords:  CONGESTIVE HEART FAILURE/therapy; HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use

Mesh:

Substances:

Year:  1953        PMID: 13019931     DOI: 10.1161/01.cir.7.2.169

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE.

Authors:  D T MASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

2.  Cardiac, hemodynamic and renal functions in congestive heart failure during induced peripheral vasodilatation; relationship to Starling's law of the heart in man.

Authors:  B J SOBOL; R H KESSLER; B RADER; L W EICHNA
Journal:  J Clin Invest       Date:  1959-03       Impact factor: 14.808

3.  [Circulation factors in deep lowering of arterial pressure by ganglion blocking agents].

Authors:  F PARR; K W SCHNEIDER
Journal:  Arch Kreislaufforsch       Date:  1957-07

4.  The role of venous constriction in circulatory disorders.

Authors:  J P RADO; E GONDA; E KOVACS
Journal:  Br Heart J       Date:  1958-07

5.  Studies of pulmonary hypertension. IX. The effects of intravenous hexamethonium on pulmonary circulation in patients with mitral stenosis.

Authors:  P N YU; R E NYE; F W LOVEJOY; B F SCHREINER; B J YIM
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

6.  Hypertension and its control by hexamethonium.

Authors:  K S SMITH; P B FOWLER; V EDMUNDS
Journal:  Br Med J       Date:  1954-11-27

7.  [Cardiac catheterization studies in severe hexamethonium-induced hypotension].

Authors:  H VETTER; G GRABNER; F MLCZOCH; K STEINBEREITHNER
Journal:  Klin Wochenschr       Date:  1954-02-01

8.  The hemodynamic effects of hypotensive drugs in man. III. Hexamethonium.

Authors:  E D FREIS; J C ROSE; E A PARTENOPE; T F HIGGINS; R T KELLEY; H W SCHNAPER; R L JOHNSON
Journal:  J Clin Invest       Date:  1953-12       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.